Literature DB >> 15840580

Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization.

Paula Berkowitz1, Peiqi Hu, Zhi Liu, Luis A Diaz, Jan J Enghild, Michael P Chua, David S Rubenstein.   

Abstract

In the human autoimmune blistering disease pemphigus vulgaris (PV) pathogenic antibodies bind the desmosomal cadherin desmoglein-3 (dsg3), causing epidermal cell-cell detachment (acantholysis). Pathogenic PV dsg3 autoantibodies were used to initiate desmosome signaling in human keratinocyte cell cultures. Heat shock protein 27 (HSP27) and p38MAPK were identified as proteins rapidly phosphorylated in response to PV IgG. Inhibition of p38MAPK activity prevented PV IgG-induced HSP27 phosphorylation, keratin filament retraction, and actin reorganization. These observations suggest that PV IgG binding to dsg3 activates desmosomal signal transduction cascades leading to (i) p38MAPK and HSP27 phosphorylation and (ii) cytoskeletal reorganization, supporting a mechanistic role for signaling in PV IgG-induced acantholysis. Targeting desmosome signaling via inhibition of p38MAPK and HSP27 phosphorylation may provide novel treatments for PV and other desmosome-associated blistering diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840580     DOI: 10.1074/jbc.M501365200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  94 in total

1.  p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.

Authors:  Xuming Mao; Yasuyo Sano; Jin Mo Park; Aimee S Payne
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  Modulation of Mechanical Stress Mitigates Anti-Dsg3 Antibody-Induced Dissociation of Cell-Cell Adhesion.

Authors:  Xiaowei Jin; Jordan Rosenbohm; Eunju Kim; Amir Monemian Esfahani; Kristina Seiffert-Sinha; James K Wahl; Jung Yul Lim; Animesh A Sinha; Ruiguo Yang
Journal:  Adv Biol (Weinh)       Date:  2021-01-04

Review 3.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies.

Authors:  Volker Spindler; Franziska Vielmuth; Enno Schmidt; David S Rubenstein; Jens Waschke
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

5.  Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Ali Karaouni; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

6.  Comparison of reactivity and epitope recognition between sera from American and Italian patients with oral pemphigoid.

Authors:  M Mignogna; A Lanza; L Rossiello; V Ruocco; A R Ahmed
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

7.  Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus acantholysis.

Authors:  Hua En Lee; Paula Berkowitz; Puneet S Jolly; Luis A Diaz; Michael P Chua; David S Rubenstein
Journal:  J Biol Chem       Date:  2009-03-07       Impact factor: 5.157

Review 8.  Desmosomes: just cell adhesion or is there more?

Authors:  Ansgar Schmidt; Peter J Koch
Journal:  Cell Adh Migr       Date:  2007-01-26       Impact factor: 3.405

9.  Keratinocytes produce IL-6 in response to desmoglein 1 cleavage by Staphylococcus aureus exfoliative toxin A.

Authors:  Cleo E Rolle; Juan Chen; Irena Pastar; Tatiana C P Cardenas; Roberto Perez; Suzanne Hower; Franco Ferracci; Richard Snyder; Marjana Tomic-Canic; Lisa R W Plano
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor.

Authors:  Wolfgang-Moritz Heupel; Peter Engerer; Enno Schmidt; Jens Waschke
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.